SEC Filing Summary: BioSig Technologies, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on October 23, 2015, covering events occurring on October 19, 2015. The filing addresses changes to the Company's Board of Directors and associated compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and equity compensation events rather than financial performance.
Material Changes
- Board Departure: Asher Holzer resigned as a member of the Board of Directors, effective October 19, 2015.
- Board Appointment: Donald E. Foley was appointed to the Board of Directors and the Nominating and Corporate Governance Committee, effective October 19, 2015.
- Compensatory Arrangements: Mr. Foley received a grant of stock options (the "Foley Grant") consisting of:
- 250,000 shares for Board service, vesting quarterly over ten years.
- 25,000 shares for Committee service, vesting monthly over twelve months.
- Both grants have an exercise price equal to the fair market value on the Date of Grant and a ten-year term.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies were disclosed in this report, other than the standard vesting conditions tied to Mr. Foley's continued service.
Investor Verification Checklist
- Verify the exact "Date of Grant" to determine the specific exercise price for Mr. Foley's stock options.
- Review the BioSig Technologies, Inc. 2012 Equity Incentive Plan for full terms and conditions of the grants.
- Confirm the status of the Board seat previously held by Asher Holzer and any potential impact on committee compositions.
- Check subsequent filings for the formal press release referenced as Exhibit 99.1.